Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
June 16, 2009
[Preoperative concomitant radiochemotherapy in bulky carcinoma of the cervix: Institut Curie experience]
Y M Kirova, Z Bourhaleb, S Alran, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie
|
August 1, 1996
Hematopoiesis research in aplastic anaemia induced by accidental protracted radiation
G Socié, K Medhi Sohrabi, E D Carosella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2000
Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction
P de Cremoux, J M Extra, M G Denis, et al.
The International Journal of Biological Markers
|
July 5, 2003
Medullary breast carcinoma: prognostic implications of p53 expression
R Dendale, A Vincent-Salomon, E Mouret-Fourme, et al.
Breast Cancer Research and Treatment
|
September 5, 2016
BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy
A S Hamy, I Bieche, J Lehmann-Che, et al.
British Journal of Cancer
|
September 30, 2010
Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation
L de Plater, A Laugé, C Guyader, et al.
Breast Cancer Research and Treatment
|
October 18, 2011
Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenografts
P Cottu, E Marangoni, F Assayag, et al.
Breast (Edinburgh, Scotland)
|
October 8, 2013
Challenging single- and multi-probesets gene expression signatures of pathological complete response to neoadjuvant chemotherapy in breast cancer: experience of the REMAGUS 02 phase II trial
F Valet, P de Cremoux, F Spyratos, et al.
Leukemia
|
July 1, 1997
Multicentric evaluation of the MDR phenotype in leukemia. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hôpitaux de Paris
J P Marie, S Huet, A M Faussat, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
June 16, 2009
[Preoperative concomitant radiochemotherapy in bulky carcinoma of the cervix: Institut Curie experience]
Y M Kirova, Z Bourhaleb, S Alran, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie
|
August 1, 1996
Hematopoiesis research in aplastic anaemia induced by accidental protracted radiation
G Socié, K Medhi Sohrabi, E D Carosella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2000
Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction
P de Cremoux, J M Extra, M G Denis, et al.
The International Journal of Biological Markers
|
July 5, 2003
Medullary breast carcinoma: prognostic implications of p53 expression
R Dendale, A Vincent-Salomon, E Mouret-Fourme, et al.
Breast Cancer Research and Treatment
|
September 5, 2016
BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy
A S Hamy, I Bieche, J Lehmann-Che, et al.
British Journal of Cancer
|
September 30, 2010
Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation
L de Plater, A Laugé, C Guyader, et al.
Breast Cancer Research and Treatment
|
October 18, 2011
Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenografts
P Cottu, E Marangoni, F Assayag, et al.
Breast (Edinburgh, Scotland)
|
October 8, 2013
Challenging single- and multi-probesets gene expression signatures of pathological complete response to neoadjuvant chemotherapy in breast cancer: experience of the REMAGUS 02 phase II trial
F Valet, P de Cremoux, F Spyratos, et al.
Leukemia
|
July 1, 1997
Multicentric evaluation of the MDR phenotype in leukemia. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hôpitaux de Paris
J P Marie, S Huet, A M Faussat, et al.
Page
of 6